Modified-FLAI Induction and Consolidation Chemotherapy in Elderly Patient With Acute Myeloid Leukemia (AML)
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
A phase II clinical trial evaluating the efficacy and tolerability of induction and
consolidation chemotherapy comprising Fludarabine, cytarabine and attenuated-dose Idarubicin
(modified-FLAI) in the elderly patients with acute myeloid leukemia.